deltatrials
Completed NCT00202657

Observational Study of Heart Valve Disease in Patients With Parkinson's Disease Treated With Pergolide

Etude Observationnelle Des Valvulopathies Chez Les Patients Parkinsoniens Traites Par Pergolide Par Rapport a Une Population Temoin

Sponsor: Institut National de la Santé Et de la Recherche Médicale, France

Conditions Parkinson's Disease Pergolide
Interventions echocardiography
Updated 6 times since 2017 Last updated: Dec 5, 2011 Started: Apr 30, 2005 Completion: Feb 28, 2007

A observational or N/A phase clinical study on Parkinson's Disease and Pergolide, this trial is completed. The trial is conducted by Institut National de la Santé Et de la Recherche Médicale, France and has accumulated 6 data snapshots since 2005. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Change History

6 versions recorded

  1. Sep 2024 — Present [monthly]

    Completed

  2. Jul 2024 — Sep 2024 [monthly]

    Completed

  3. Jan 2021 — Jul 2024 [monthly]

    Completed

  4. Jun 2018 — Jan 2021 [monthly]

    Completed

  5. Apr 2018 — Jun 2018 [monthly]

    Completed

    Phase: PHASE4 → None

▶ Show 1 earlier version

  1. Jan 2017 — Apr 2018 [monthly]

    Completed PHASE4

    First recorded

Apr 2005

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Institut National de la Santé Et de la Recherche Médicale, France
  • Société Française de Cardiologie
Data source: Société Française de Cardiologie

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

  • • Paris, France